392 related articles for article (PubMed ID: 27396511)
21. Xeroderma pigmentosum and related disorders: defects in DNA repair and transcription.
Berneburg M; Lehmann AR
Adv Genet; 2001; 43():71-102. PubMed ID: 11037299
[TBL] [Abstract][Full Text] [Related]
22. Two new XPD patients compound heterozygous for the same mutation demonstrate diverse clinical features.
Fujimoto M; Leech SN; Theron T; Mori M; Fawcett H; Botta E; Nozaki Y; Yamagata T; Moriwaki S; Stefanini M; Momoi MY; Nakagawa H; Shuster S; Moss C; Lehmann AR
J Invest Dermatol; 2005 Jul; 125(1):86-92. PubMed ID: 15982307
[TBL] [Abstract][Full Text] [Related]
23. An Xpd mouse model for the combined xeroderma pigmentosum/Cockayne syndrome exhibiting both cancer predisposition and segmental progeria.
Andressoo JO; Mitchell JR; de Wit J; Hoogstraten D; Volker M; Toussaint W; Speksnijder E; Beems RB; van Steeg H; Jans J; de Zeeuw CI; Jaspers NG; Raams A; Lehmann AR; Vermeulen W; Hoeijmakers JH; van der Horst GT
Cancer Cell; 2006 Aug; 10(2):121-32. PubMed ID: 16904611
[TBL] [Abstract][Full Text] [Related]
24. Restoring DNA repair capacity of cells from three distinct diseases by XPD gene-recombinant adenovirus.
Armelini MG; Muotri AR; Marchetto MC; de Lima-Bessa KM; Sarasin A; Menck CF
Cancer Gene Ther; 2005 Apr; 12(4):389-96. PubMed ID: 15650764
[TBL] [Abstract][Full Text] [Related]
25. UV damage causes uncontrolled DNA breakage in cells from patients with combined features of XP-D and Cockayne syndrome.
Berneburg M; Lowe JE; Nardo T; Araújo S; Fousteri MI; Green MH; Krutmann J; Wood RD; Stefanini M; Lehmann AR
EMBO J; 2000 Mar; 19(5):1157-66. PubMed ID: 10698956
[TBL] [Abstract][Full Text] [Related]
26. Defects in the DNA repair and transcription gene ERCC2 in the cancer-prone disorder xeroderma pigmentosum group D.
Takayama K; Salazar EP; Lehmann A; Stefanini M; Thompson LH; Weber CA
Cancer Res; 1995 Dec; 55(23):5656-63. PubMed ID: 7585650
[TBL] [Abstract][Full Text] [Related]
27. Novel XPG (ERCC5) mutations affect DNA repair and cell survival after ultraviolet but not oxidative stress.
Soltys DT; Rocha CR; Lerner LK; de Souza TA; Munford V; Cabral F; Nardo T; Stefanini M; Sarasin A; Cabral-Neto JB; Menck CF
Hum Mutat; 2013 Mar; 34(3):481-9. PubMed ID: 23255472
[TBL] [Abstract][Full Text] [Related]
28. Defective transcription-coupled repair of oxidative base damage in Cockayne syndrome patients from XP group G.
Cooper PK; Nouspikel T; Clarkson SG; Leadon SA
Science; 1997 Feb; 275(5302):990-3. PubMed ID: 9020084
[TBL] [Abstract][Full Text] [Related]
29. Cockayne syndrome complementation group B associated with xeroderma pigmentosum phenotype.
Itoh T; Cleaver JE; Yamaizumi M
Hum Genet; 1996 Feb; 97(2):176-9. PubMed ID: 8566949
[TBL] [Abstract][Full Text] [Related]
30. The rem mutations in the ATP-binding groove of the Rad3/XPD helicase lead to Xeroderma pigmentosum-Cockayne syndrome-like phenotypes.
Herrera-Moyano E; Moriel-Carretero M; Montelone BA; Aguilera A
PLoS Genet; 2014 Dec; 10(12):e1004859. PubMed ID: 25500814
[TBL] [Abstract][Full Text] [Related]
31. Malfunction of nuclease ERCC1-XPF results in diverse clinical manifestations and causes Cockayne syndrome, xeroderma pigmentosum, and Fanconi anemia.
Kashiyama K; Nakazawa Y; Pilz DT; Guo C; Shimada M; Sasaki K; Fawcett H; Wing JF; Lewin SO; Carr L; Li TS; Yoshiura K; Utani A; Hirano A; Yamashita S; Greenblatt D; Nardo T; Stefanini M; McGibbon D; Sarkany R; Fassihi H; Takahashi Y; Nagayama Y; Mitsutake N; Lehmann AR; Ogi T
Am J Hum Genet; 2013 May; 92(5):807-19. PubMed ID: 23623389
[TBL] [Abstract][Full Text] [Related]
32. Nucleotide excision repair and cancer.
Leibeling D; Laspe P; Emmert S
J Mol Histol; 2006 Sep; 37(5-7):225-38. PubMed ID: 16855787
[TBL] [Abstract][Full Text] [Related]
33. Development of a new easy complementation assay for DNA repair deficient human syndromes using cloned repair genes.
Carreau M; Eveno E; Quilliet X; Chevalier-Lagente O; Benoit A; Tanganelli B; Stefanini M; Vermeulen W; Hoeijmakers JH; Sarasin A
Carcinogenesis; 1995 May; 16(5):1003-9. PubMed ID: 7767957
[TBL] [Abstract][Full Text] [Related]
34. A common mutational pattern in Cockayne syndrome patients from xeroderma pigmentosum group G: implications for a second XPG function.
Nouspikel T; Lalle P; Leadon SA; Cooper PK; Clarkson SG
Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3116-21. PubMed ID: 9096355
[TBL] [Abstract][Full Text] [Related]
35. Xeroderma pigmentosum-Cockayne syndrome complex.
Natale V; Raquer H
Orphanet J Rare Dis; 2017 Apr; 12(1):65. PubMed ID: 28376890
[TBL] [Abstract][Full Text] [Related]
36. Cancer in xeroderma pigmentosum and related disorders of DNA repair.
Cleaver JE
Nat Rev Cancer; 2005 Jul; 5(7):564-73. PubMed ID: 16069818
[TBL] [Abstract][Full Text] [Related]
37. Human cancer and DNA repair-deficient diseases.
Sarasin A; Stary A
Cancer Detect Prev; 1997; 21(5):406-11. PubMed ID: 9307843
[TBL] [Abstract][Full Text] [Related]
38. Early-onset nucleotide excision repair disorders with neurological impairment: Clues for early diagnosis and prognostic counseling.
Baer S; Obringer C; Julia S; Chelly J; Capri Y; Gras D; Baujat G; Felix TM; Doray B; Sanchez Del Pozo J; Ramos LM; Burglen L; Laugel V; Calmels N
Clin Genet; 2020 Sep; 98(3):251-260. PubMed ID: 32557569
[TBL] [Abstract][Full Text] [Related]
39. XPG stabilizes TFIIH, allowing transactivation of nuclear receptors: implications for Cockayne syndrome in XP-G/CS patients.
Ito S; Kuraoka I; Chymkowitch P; Compe E; Takedachi A; Ishigami C; Coin F; Egly JM; Tanaka K
Mol Cell; 2007 Apr; 26(2):231-43. PubMed ID: 17466625
[TBL] [Abstract][Full Text] [Related]
40. Oxidative damage-induced PCNA complex formation is efficient in xeroderma pigmentosum group A but reduced in Cockayne syndrome group B cells.
Balajee AS; Dianova I; Bohr VA
Nucleic Acids Res; 1999 Nov; 27(22):4476-82. PubMed ID: 10536158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
